MENU
ANRO
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Alto Neuroscience (ANRO) Ownership - Who owns Alto Neuroscience?

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals’ neurobiology to develop personalized and effective treatment options... Show more

Profile

Industry
N/A
Address
369 South San Antonio Road
Phone
+1 650 200-0412
Employees
63
Web
https://www.altoneuroscience.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
99.37M
P/E Ratio
N/A
Total Cash
147.59M
Projected Growth
N/A
Total Debt
27.31M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
5.45
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

ANRO
Capitalization
99.4M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
148M
Total Cash/Share
5.45
Total Debt
27.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
123M
P/B Ratio
0.77
Cash Flow
N/A
Earnings
-2.39
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
18.43
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-62.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-36.52
Shares Held By Institutions
59.7M
Shares Outstanding - Current
27.1M
Total Liabilities
34.5M
Total Volume MTD
N/A
Value
1
Gain YTD
-13.239
View a ticker or compare two or three
ANRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ANRO showed earnings on August 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
369 South San Antonio Road
Phone
+1 650 200-0412
Employees
63
Web
https://www.altoneuroscience.com